<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-pharmaceuticals-12-00147">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Manini</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Domnich</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Amicizia</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Rossi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pozzi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gasparini</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Panatto</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Montomoli</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Flucelvax (Optaflu) for seasonal influenza</article-title>
  <source>Expert Rev. Vaccines</source>
  <year>2015</year>
  <volume>14</volume>
  <fpage>789</fpage>
  <lpage>804</lpage>
  <pub-id pub-id-type="doi">10.1586/14760584.2015.1039520</pub-id>
  <?supplied-pmid 25968069?>
  <pub-id pub-id-type="pmid">25968069</pub-id>
 </element-citation>
</ref>
